MAP2K7 and colorectal carcinoma: In addition, in vivo treatment of the C26 CRC cell line with dual PD-L1 and MEK inhibition increased suppression of tumor growth and led to more durable responses than did either agent alone, which can be explained through priming of the immune response by inhibition of MEK [25].